Drug Report History

Return to report

Below you will find the report version history. When a report is updated, a new version of the report is created. The report history allows you to see the changes between versions. You can select two versions of the report to compare. The fields that were changed between versions will be highlighted in yellow.

The translation of reports creates two separate versions which is why some reports may not seem to have any differences. In this case, only the language field below will be highlighted in yellow.

Version v7-FR Version v7-FR
Language French French
Date Updated 2020-07-10 2020-07-10
Drug Identification Number 02296640 02296640
Brand name TEVA-RABEPRAZOLE EC TEVA-RABEPRAZOLE EC
Common or Proper name RABEPRAZOLE 20MG TAB RABEPRAZOLE 20MG TAB
Company Name TEVA CANADA LIMITED TEVA CANADA LIMITED
Ingredients RABEPRAZOLE SODIUM RABEPRAZOLE SODIUM
Strength(s) 20MG 20MG
Dosage form(s) TABLET (DELAYED-RELEASE) TABLET (DELAYED-RELEASE)
Route of administration ORAL ORAL
Packaging size 100 100
ATC code A02BC A02BC
ATC description DRUGS FOR PEPTIC ULCER AND GASTROESOPHAGEAL REFLUX DISEASE (GERD) DRUGS FOR PEPTIC ULCER AND GASTROESOPHAGEAL REFLUX DISEASE (GERD)
Reason for shortage Other (Please describe in comments) Other (Please describe in comments)
Anticipated start date
Actual start date 2020-02-07 2020-02-07
Estimated end date
Actual end date 2020-03-25 2020-03-25
Shortage status Resolved Resolved
Tier 3 Status No No
Company comments Item is discontinued. Item is discontinued.
Health Canada comments